ERUC ER Urgent Care Holdings Inc (CE)

ER Urgent Care Holdings, Inc. (Pink Sheets: ERUC) has been rated �Speculative Buy� with a target price of $0.90 by Beacon Equity Research Analyst, Lisa Springer, CFA. The full report is available at http://www.BeaconEquityResearch.com Anyone interested in receiving alerts regarding ER Urgent Care Holdings, Inc. research should email members@beaconequityresearch.com with �ERUC� in the subject line. In the report, the analyst writes, �ER Urgent Care Holdings, Inc. provides medical care services through its network of three primary care facilities and eight urgent care facilities. The Company is a one-stop shop for healthcare, providing a wide range of urgent healthcare services and general health care programs, after physician office hours and at costs significantly lower than emergency room visits. Urgent care centers are a rapidly growing business with significant growth potential. The market for healthcare services provided outside regular physician office hours is largely underserved. These centers are becoming increasing popular options for patients with non-life threatening conditions who wish to avoid the high costs and long waits associated with emergency room visits. � Publicly-traded companies in this healthcare services space or related areas include Symbion (NASDAQ:SMBI), AmSurg Corp (NASDAQ:AMSG), Horizon Health (NASDAQ:HORC) and Rehabcare Group (NYSE:RHB). Beacon Equity Research Disclosure The analysts contributing to this report do not hold any shares of ER Urgent Care Holdings, Inc. (ERUC). Additionally, the analysts contributing to this report certify that the views expressed herein accurately reflect the analysts' personal views as to the subject securities and issuers. The analyst(s) writing this report recognize and aspire to all of the CFA Institute Guidelines for Independent Research. Beacon Equity Research (�Beacon�) certifies that no part of the analysts' compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analysts in the report. Beacon has directly been compensated nine thousand dollars from RR Investments for enrollment of ER Urgent Care in its research program. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. As such, the report should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed herein are subject to change.